Brief: Geron Announces Publication In The Lancet Of Results From The IMerge Phase 3 Clinical Trial Evaluating Imetelstat In Lower Risk MDS
04/12/2023 15:19
Dec 4 (Reuters) - Geron Corp GERN.O :
* GERON ANNOUNCES PUBLICATION IN THE LANCET OF RESULTS FROM
THE
IMERGE PHASE 3 CLINICAL TRIAL EVALUATING IMETELSTAT IN LOWER
RISK MDS
Source text for Eikon: ID:nBw3vKdYMa
Further company coverage: GERN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Geron
See all newsBrief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Geron Corporation reports results for the quarter ended June 30 - Earnings Summary
Geron's Q2 revenue rises on RYTELO growth
Brief: Geron Q2 EPS USD -0.02
Brief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)